Presentation
MaaT Pharma has established a complete approach to restore patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treat blood cancers and GvHD, we have already achieved proof of concept in AML patients. Supporting the expansion of our pipeline, we have built a discovery and analysis platform to evaluate drug candidates and determine novel disease targets. Our therapeutics are produced with a standardized cGMP manufacturing and quality control process
Contact
Address
70 avenue Tony Garnier – 69007 Lyon
Website
Targeted indications : Hematologic cancer